Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2

American Journal of Pathology

Volumn 154, Issue 3, 1999, Pages 937-944

  Santiago, Fernando S ^b   Lowe, Harry C ^b   Day, Fiona L ^b   Chesterman, Colin N ^b   Khachigian, Levon M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTISENSE OLIGONUCLEOTIDE; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; AORTA; ARTICLE; BLOOD VESSEL INJURY; CATTLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; GENE EXPRESSION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; TISSUE REPAIR; VASCULAR ENDOTHELIUM;

EID: 0032996518     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65341-2     Document Type: Article

References (71)

1. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809
2. Gorlin R: Treatment of chronic stable angina pectoris. Am J Cardiol 1992, 70 26G-31G
3. Mishkel GJ, Marquis JF: Restenosis and accelerated left main coronary artery disease presenting six months after successful percutaneous transluminal coronary angioplasty. Can J Cardiol 1989, 5:187-190
4. Wayne VS, Harper RW, Pitt A: Left main coronary artery stenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988, 61:459-460
5. Waller BF, Pinkerton CA, Foster LN: Morphologic evidence of accelerated left main coronary artery stenosis: a late complication of percutaneous transluminal balloon angioplasty of the proximal left anterior descending coronary artery. J Am Coll Cardiol 1987, 9:1019-1023
6. Hamad N, Pichard A, Oboler A, Lindsay J: Left main coronary artery stenosis as a late complication of percutaneous transluminal coronary angioplasty. Am J Cardiol 1987, 60:1183-1184
7. Lindner V, Reidy MA, Fingerle J: Regrowth of arterial endothelium: denudation with minimal trauma leads to complete endothelial cell regrowth. Lab Invest 1989, 61:556-563
8. Lindner V: Expression of platelet-derived growth factor ligands and receptors by rat aortic endothelium in vivo. Pathobiology 1995, 63: 257-264
9. Miano JM, Vlasic N, Tota RR, Stemerman MB: Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury: a putative mechanism for autocrine growth. Arterioscler Thromb 1993, 13:211-219
10. Lindner V, Reidy MA: Platelet-derived growth factor ligand and receptor expression by large vessel endothelium. Am J Pathol 1995, 146:1488-1497
11. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM: PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990, 111:2149-2158
12. Lindner V, Giachelli CM, Schwartz SM, Reidy MA: A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor-B chain mRNA. Circ Res 1995, 76:951-957
13. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA: Production of transforming growth factor-β1 during repair of arterial injury. J Clin Invest 1991, 88:904-910
14. Khachigian LM, Lindner V, Williams AJ, Collins T: Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 1996, 271:1427-1431
15. Biesiada E, Razandi M, Levin ER: Egr-1 activates basic fibroblast growth factor transcription. J Biol Chem 1996, 271:18576-18581
16. Hu R-M, Levin ER: Astrocyte growth factor is regulated by neuropeptides through Tis 8 and basic fibroblast growth factor. J Clin Invest 1994, 93:1820-1827
17. Sukhatme VP, Cao X, Chang LL, Tsai-Morris C-H, Stamenkovich D, Ferreira PCP, Cohen DR, Edwards SA, Shows TB, Curran T: A zinc-finger encoding gene corregulated with c-Fos during growth and differentiation and after depolarization. Cell 1988, 53:37-43
18. Gashler A, Sukhatme V: Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acids Res 1995, 50:191-224
19. Nakagama H, Heinrich G, Pelletier J, Housman DE: Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol 1995, 15:1489-1498
20. Swirnoff AH, Milbrandt J: NGFI-A and related zinc-finger transcription factors. Mol Cell Biol 1995, 15:2275-2287
21. Khachigian LM, Anderson KA, Halnon NJ, Resnick N, Gimbrone MA Jr, Collins T: Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress response element in the PDGF A-chain promoter. Arterioscler Thromp Vasc Biol 1997, 17:2280-2286
22. Khachigian LM, Williams AJ, Collins T: Interplay of Sp1 and Egr-1 in the proximal PDGF-A promoter in cultured vascular endothelial cells. J Biol Chem 1995, 270:27679-27686
23. Schwartz SM: Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 1997, 99:2814-2817
24. Silverman ES, Khachigian LM, Lindner V, Williams AJ, Collins T: Inducible PDGF A-chain transcription in vascular smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3. Am J Physiol 1997, 42:H1415-H1426
25. Khachigian LM, Collins T: Inducible expression of Egr-1-dependent genes: a paradigm of transcriptional activation in vascular endothelium. Circ Res 1997, 81:457-461
26. Jaye M, Howk R, Burgess W, Ricca GA, Chiu IM, Ravera MW, O'Brien SJ, Modi WS, Maciag T, Drohan WN: Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosomal localization. Science 1986, 233:541-545
27. Lindner V, Reidy MA: Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries: an en face study. Circ Res 1993, 73:589-595
28. Vlodavsky I, Friedman R, Sullivan R, Sasse J, Klagsbrun M: Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor which is secreted. J Cell Physiol 1987, 131:402-408
29. Jones KA, Kadonaga JT, Rosenfeld PJ, Kelly TJ, Tjian R: A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 1987, 48:79-89
30. Bonthron DT, Morton CC, Orkin SH, Collins T: Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing. Proc Natl Acad Sci USA 1988, 85:1492-1496
31. Delbridge GJ, Khachigian LM: FGF-1-induced PDGF A-chain gene expression in vascular endothelial cells involves transcriptional activation by Egr-1. Circ Res 1997, 81:282-288
32. Norman C, Runswick M, Pollock R, Treisman R: Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 1988, 55:989-1003
33. Treisman R: Ternary complex factor: growth factor regulated transcriptional activators. Curr Opin Genet Dev 1994, 4:96-101
34. Cohen DM: Urea-inducible Egr-1 transcription in renal inner medullary collecting duct (MIMCD3) cells is mediated by extracellular signal-regulated kinase activation. Proc Natl Acad Sci USA 1996, 93: 11242-11247
35. Cohen DM, Gullans SR, Chin WW: Urea inducibility of egr-1 in murine inner medullary collecting duct cells is mediated by the serum response element and adjacent Ets motifs. J Biol Chem 1996, 271: 12903-12908
36. McMahon SB, Monroe JG: A ternary complex factor-dependent mechanism mediates induction of egr-1 through selective serum response elements following antigen receptor cross-linking in B lymphocytes. Mol Cell Biol 1995, 15:1086-1093
37. Thompson MJ, Roe MW, Malik RK, Blackshear PJ: Insulin and other growth factors induce binding of the ternary complex and a novel protein complex to the c-fos serum response element. J Biol Chem 1994, 269:21127-21135
38. Treisman R: The SRE: a growth factor responsive transcriptional regulator. Semin Cancer Biol 1990, 1:47-58
39. Christy B, Nathans D Functional serum response elements upstream of the growth factor-inducible gene, zif268. Mol Cell Biol 1989, 9:4889-4895
40. Herrera RE, Shaw PE, Nordheim A: Occupation of the c-fos serum response element in vivo by a multi-protein complex is unaltered by growth factor induction. Nature 1989, 340:68-70
41. Gille H, Kortenjann M, Strahl T, Shaw PE: Phosphorylation-dependent formation of a quaternary complex at the c-fos SRE. Mol Cell Biol 1996, 16:1094-1102
42. Rupprecht HD, Sukhatme VP, Lacy J, Sterzel RB, Coleman DL: PDGF-induced Egr-1 expression in rat mesangial cells is mediated through upstream serum response elements. Am J Physiol 1993, 265:F351-F360
43. Alexandropoulos K, Qureshi SA, Rim M, Sukhatme VP, Foster DA: v-Fps-responsiveness in the Egr-1 promoter is mediated by serum response elements Nucleic Acids Res 1992, 20:2355-2359
44. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase k nase in vitro and in vivo. J Biol Chem 1995, 270:27489-27494
45. Janknecht R, Hunter T: Activation of the Sap-1a transcription factor by the c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase. J Biol Chem 1997, 272:4219-4224
46. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ: Integration of MAP kinase signal transduction pathways at the serum response element. Science 1995, 269:403-407
47. Price M-A, Rogers AE, Treisman R: Comparative analysis of the ternary complex factors Elk-1, SAP-1a, and SAP-2 (ERP/NET). EMBO J 1995, 14:2589-2601
48. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, Shaw PE: ERK phosphorylation potentiates ELK-1-mediated ternary complex formation and transactivation. EMBO J 1995, 14:951-962
49. Lopez-Ilasaca M, Li W, Uren A, Yu JC, Kazlauskas A, Gutkind JS, Heideran MA: Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPK by PDGF. Biochem Biophys Res Commun 1997, 232:272-277
50. Logan SK, Falasca M, Hu P, Schlessinger J: Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway. Mol Cell Biol 1997, 17: 5784-5790
51. Ishizuka T, Terada N, Gerwins P, Hamelmann E, Oshiba A, Fanger GR, Gelfand EW: Mast cell tumor necrosis factor α production is regulated by MEK kinases. Proc Natl Acad Sci USA 1997, 94:6358-6363
52. Ishizuka T, Oshiba A, Sakata N, Johnson GL, Gelfand EW: Aggregation of the FcERI on mast cells stimulates c-Jun amino-terminal kinase activity. J Biol Chem 1996, 271:12762-12766
53. Derijard B, Hibi M, Wu I-H, Barrett T, Su B, Deng T, Karin M, Davis RJ: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76:1025-1037
54. Cazenave C, Stein C, Loreau N, Thuong N, Neckers L, Subasinghe C, Helene C, Cohen J, Toulme J: Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides. Nucleic Acids Res 1989, 17:4225-4273
55. Marcus-Sekura C, Woerner A, Shinozuka K, Zon G, Quinnan G: Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl triester, methyl phosphonate and phosphorothioate linkages. Nucleic Acids Res 1987, 15:5749-5763
56. Wang W, Chen HJ, Schwartz A, Cannon PJ, Stein CA, Rabbani LE: Sequence-independent inhibition of in vitro smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligonucleotides. J Clin Invest 1996, 98:443-450
57. Guvakova MA, Yakubov LA, Vlodavsky I, Tonkinson JL, Stein CA: Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J Biol Chem 1995, 270:2620-2627
58. Krieg AM, Stein CA: Phosphorothioate oligonucleotides: antisense or anti-protein? Antisense Res Dev 1995, 5:241
59. Villa AE, Guzman LA, Poptic EJ, Labhasetwar V, D'Souza S, Farrell CL, Plow EF, Levy RJ, DiCorleto PE, Topol EJ: Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. Circ Res 1995, 76:505-513
60. Hallahan DE, Dunphy E, Virudachalam S, Sukhatme VP, Kufe DW, Weischselbaum RR: c-jun and Egr-1 participate in DNA synthesis and cell survival in response to ionizing radiation exposure. J Biol Chem 1995, 270:30303-30309
61. Hofer G, Grimmer C, Sukhatme VP, Sterzel RB, Rupprecht HD: Transcription factor Egr-1 regulates glomerular mesangial cell proliferation. J Biol Chem 1996, 271:28306-28310
62. Szklarczyk A, Blaszczyk J, Kaczmarek L: Antisense oligonucleotides against transcription factor Zif 268 transiently impair excitatory synaptic transmission in the hippocampus without affecting Zif 268 immunoreactivity. Neurosci Res Commun 1996, 19:125-133
63. Lindner V, Fingerle J, Reidy MA: Mouse model of arterial injury. Circ Res 1993, 73:792-796
64. Lowe HC, Chesterman CN, Khachigian LM: Left main coronary artery stenosis after percutaneous transluminal coronary angioplasty: importance of remaining "minimally invasive". Catheter Cardiovasc Diagn 1999 (in press)
65. Kraiss LW, Clowes AW: Response of the arterial wall to injury and intimal hyperplasia. The Basic Science of Vascular Disease. Edited by Sidawy AN, Sumpio BE, Depalma RG, Armonk, NY, Futura, 1997, pp 289-317
66. Pap JM: Catheter-induced intimai injury during routine coronary catheterization in dogs. Catheter Cardiovasc Diagn 1987, 13:57-73
67. Lindner V, Reidy MA: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991, 88:3739-3743
68. Olson NE, Chao S, Lindner V, Reidy MA: Intimal smooth muscle cell proliferation after balloon catheter injury: the role of bas c fibroblast growth factor. Am J Pathol 1992, 140:1017-1023
69. Lee SL, Sadovsky Y, Swirnoff AH, Polish JA, Goda P, Gavrilina G, Milbrandt J: Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGF-IA (Egr-1). Science 1996, 273:1219-1221
70. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C: Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA 1996, 95:5672-5677
71. Koyama H, Olson NE, Dastvan FF, Reidy MA: Cell replication in the arterial wall: activation of signaling pathway following in vivo injury. Circ Res 1998, 82:713-721